Efficacy of polyethylene glycol loxenatide versus insulin glargine on glycemic control in patients with type 2 diabetes: a randomized, open-label, parallel-group trial

• Autors principals: Shuo Zhang (Autor), Chuanyan Zhang (Autor), Jingxian Chen (Autor), Feiying Deng (Autor), Zezhen Wu (Autor), Dan Zhu (Autor), Fengwu Chen (Autor), Yale Duan (Autor), Yue Zhao (Autor), Kaijian Hou (Autor)
• Format: Llibre
• Publicat: Frontiers Media S.A., 2023-05-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Objective: This trial aimed to evaluate the glycemic control of polyethylene glycol loxenatide measured with continuous glucose monitoring (CGM) in patients with type 2 diabetes mellitus (T2DM), with the hypothesis that participants given PEG-Loxe would spend more time in time-in-range (TIR) than pa...